SCHEMBL7449461

SCHEMBL7449461

N#CCNC(=O)C(CNC(=O)c1ccc(-c2csc(NC(=N)N)n2)cc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.47
CTSK P43235 3/20 0.47
SCD O00767 1/20 0.45
MASP2 O00187 1/20 0.44
F2 P00734 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CTSB P07858 2/20 0.44
CTSL P07711 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
ROCK1 Q13464 3/20 0.43
PARP1 P09874 1/20 0.42
ROCK2 O75116 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182776 0.83 CTSS (0.64) CTSSCTSKCTSBCTSL
SCHEMBL7455830 0.82 KMT2A (0.44) SCDMASP2F2ADORA3MEN1
SCHEMBL6186012 0.82 ALDH1A1 (0.50) SCDMASP2F2ADORA3CTSB
SCHEMBL4714775 0.82 CTSK (0.58) CTSSCTSKCTSBCTSL
SCHEMBL4713449 0.80 CTSK (0.64) CTSSCTSKCTSBCTSL
SCHEMBL7429047 0.80 CSNK2A1 (0.49) CTSSCTSKCTSBCTSLMEN1
SCHEMBL6181733 0.78 KMT2A (0.47) SCDADORA3MEN1KMT2AKDM4E
SCHEMBL6184390 0.76 CTSL (0.59) CTSSCTSKCTSBCTSL
SCHEMBL6266978 0.76 CTSL (0.43) CTSSCTSKCTSBCTSLMEN1
SCHEMBL5517758 0.76 CTSK (0.61) CTSSCTSKCTSBCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161415-A2 N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-12 EP disclosed
WO-2000055126-A2 N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed